Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Glaxosmithkline Plc
(NY:
GSK
)
38.20
USD
-1.05 (-2.66%)
Streaming Delayed Price
Updated: 2:59 PM EST, Jan 27, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Glaxosmithkline Plc
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
UPDATE 1-FDA panel backs Glaxo asthma drug for adults, not adolescents
March 19, 2015
March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma, but not adolescents, an advisory panel to the U.S....
Tags
companyNews
From
Reuters: Company News
FDA panel backs Glaxo asthma drug for adults, not adolescents
March 19, 2015
March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma but not adolescents, an advisory panel to the U.S....
Tags
companyNews
From
Reuters: Company News
Box nabs US government IT executive
March 19, 2015
Sonny Hashmi, former CIO of the General Services Administration, will lead Box's efforts to lure government agencies to move to its cloud platform.
Tags
Boston Scientific Corp
Business/Technology/Cloud Computing
Microsoft Corp
From
CNBC.com News
Hottest Healthcare Stocks Now – LLY GSK DGX SHPG
March 18, 2015
Tags
Hot Stocks
NYSE:HCA
NYSE:LLY
From
InvestorPlace
FDA panel to discuss Ebola vaccine development in May
March 18, 2015
March 18 (Reuters) - The U.S. Food and Drug Administration said an advisory panel will discuss the development of Ebola vaccines, days after an American health worker was flown back after being tested...
Tags
companyNews
From
Reuters: Company News
Lusitanophones And Other Suspects
March 17, 2015
The largest sector, natural gas pipelines, did well, but midstream, its current no. 2 business, did poor.
Tags
Stocks / Equities
Commodities
From
Blogs - TalkMarkets
UPDATE 1-FDA staff finds no new safety problems with Glaxo's asthma drug
March 17, 2015
March 17 (Reuters) - GlaxoSmithKline Plc's respiratory treatment for chronic breathing problems did not show any new safety problems while being tested to treat asthma, a preliminary review by U.S....
Tags
companyNews
From
Reuters: Company News
FDA staff finds no new safety problems with Glaxo's asthma drug
March 17, 2015
March 17 (Reuters) - GlaxoSmithKline Plc's respiratory treatment for chronic breathing problems did not show any new safety problems in treating asthma, a preliminary review by U.S. Food and Drug...
Tags
companyNews
From
Reuters: Company News
UPDATE 1-Dementia drug research aided by $100 mln venture capital fund
March 16, 2015
* Backers include British govt, GSK, J&J, Pfizer, Lilly, Biogen
Tags
companyNews
From
Reuters: Company News
Dementia drug research aided by $100 mln venture capital fund
March 16, 2015
LONDON, March 17 (Reuters) - The world's first venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $100 million with the backing of the British government and...
Tags
companyNews
From
Reuters: Company News
Ebola booster vaccine trial to combine GSK, Emergent Bio shots
March 16, 2015
LONDON, March 16 (Reuters) - Scientists are to test a new two-shot Ebola vaccine using an experimental shot from Britain's GlaxoSmithKline, which is already in clinical trials in Africa, and a new kind...
Tags
companyNews
From
Reuters: Company News
Week In Review: Porton Fine Chemicals Buys Dongbang Pharma
March 15, 2015
Porton Fine Chemicals will acquire Jiangxi Dongbang Pharmaceutical Co., Ltd. for $41.5 million. The purchase will be paid with $16 million in cash and the remainder in stock.
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Week in Review: Porton Fine Chemicals Buys Dongbang Pharma
March 13, 2015
Porton Fine Chemicals of Chongqing will pay $42 million to acquire Jiangxi Dongbang Pharma, combining their CMO API assets; Shanghai Pharma will form a $16 million on-line drug distribution JV with...
From
ChinaBio® Today
Why biotech investors may be hurting innovation
March 13, 2015
Over the past five years, investor money is increasingly moving towards consumer software and later-stage life science ventures, a trend that could help develop new treatments.
Tags
Johnson & Johnson
Business/Mergers and Acquisitions/Venture Capital
Eli Lilly and Company
From
CNBC.com News
5 Best Countries for ETF Investment
March 13, 2015
Tags
NYSE:MCD
NYSEARCA:VOOV
NYSE:GSK
From
InvestorPlace
UPDATE 2-GSK raises $853 mln by halving stake in S.African drugmaker
March 12, 2015
* British group retains 6.2 percent stake in Aspen (Updates with actual amount raised following sale)
Tags
companyNews
From
Reuters: Company News
PRESS DIGEST- Financial Times - March 13
March 12, 2015
March 13 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Tags
companyNews
From
Reuters: Company News
Johnson & Johnson sues Glaxo over allergy ads as spring nears
March 12, 2015
NEW YORK, March 12 (Reuters) - Johnson & Johnson sued rival drugmaker GlaxoSmithKline PLC on Thursday, alleging that Glaxo is trying to unlawfully grab market share with false advertising at the start...
Tags
companyNews
From
Reuters: Company News
UPDATE 1-GSK to pocket $890 mln by halving stake in S.African drugmaker
March 12, 2015
LONDON, March 12 (Reuters) - GlaxoSmithKline has decided to take profits in Aspen Pharmacare by halving its stake in the South African drugmaker, following a long investment in the firm.
Tags
companyNews
From
Reuters: Company News
GSK's big bet: Tapping our body's electronics
March 11, 2015
GSK expects it can design technology small and smart enough to manipulate our bodies' electrical systems and create new treatments for diseases.
Tags
Politics and Government/Government Agencies/FDA
S&P 500
Biogen Idec Inc
From
CNBC.com News
Theravance Biopharma Q4 Loss Widens Y/Y, Revenues Up
March 11, 2015
Theravance Biopharma, Inc. reported fourth-quarter 2014 loss of $2.02 per share, wider than a loss of $1.39 per share incurred a year ago.
Tags
Pharma/Biotech
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
GSK to Build New Asia Headquarters in Singapore
March 11, 2015
GlaxoSmithKline announced plans for a larger Asia headquarters in Singapore, where the company currently has its Asia head office. The new space will total about 160,000 square feet and house up to...
From
ChinaBio® Today
2 Biotech Candidates With Massive Buyout Potential
March 10, 2015
If a large pharma or biotech company is looking to make a major splash in 2015, Vertex Pharmaceuticals could fit the bill.
Tags
Pharma/Biotech
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
UPDATE 1-Drugmaker GSK to steer Asian business from new Singapore HQ
March 10, 2015
* New HQ slated for completion in late 2016 (Adds details, CEO comments)
Tags
companyNews
From
Reuters: Company News
Drugmaker GSK to steer Asian business from new Singapore HQ
March 10, 2015
March 11 (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday it was establishing a new global headquarters for Asia in Singapore, strengthening its presence in the city-state.
Tags
companyNews
From
Reuters: Company News
The Global Shift
March 09, 2015
News from various lands (Switzer-, Fin-, Ire-, Nether-) and continents.
Tags
Technology
Stocks / Equities
Capital & Industrial Goods
From
Blogs - TalkMarkets
GSK sacks 110 China staff in wake of drug bribery case - sources
March 06, 2015
LONDON, March 6 (Reuters) - Drugmaker GlaxoSmithKline , which was fined 3 billion yuan ($479 million) in China last year for bribery, is dismissing 110 employees in the country for misconduct, people...
Tags
companyNews
From
Reuters: Company News
UPDATE 1-Merck-NewLink Ebola vaccine Phase III trial to start March 7
March 04, 2015
GENEVA/LONDON, March 5 (Reuters) - Final stage of testing of an experimental Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization...
Tags
companyNews
From
Reuters: Company News
Merck-NewLink Ebola vaccine Phase III trial to start March 7
March 04, 2015
GENEVA, March 5 (Reuters) - Merck & Co and NewLink Genetics Corp's Ebola vaccine will begin a Phase III trial in Guinea on March 7, the final stage of testing, the World Health Organization said on...
Tags
companyNews
From
Reuters: Company News
A New Contest; Understanding India; Global Stock Roundup
March 04, 2015
What India's new budget means for investors - plus looking for help understanding ST Microelectronics.
Tags
Stocks / Equities
Mutual Funds
From
Blogs - TalkMarkets
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.